Sinclair Pharma (SPH)
19/10/2017 - 13:25 RNS
RNS Number: 1138U Sinclair Pharma PLC 19 October 2017 Sinclair Pharma plc New CE mark granted for Silhouette Soft London, 19 October 2017 Sinclair Pharma plc (SPH.L), ("Sinclair") the international aesthetics company, is pleased to announce that Silhouette Soft has been re-issued a European CE mark, effective immediately. As previously disclosed by Sinclair,...
02/10/2017 - 06:15 RNS
RNS Number: 3141S Sinclair Pharma PLC 02 October 2017 Hardman Research: Demand growing in target markets Demand growing in target markets - In 2016 Sinclair was transformed into a streamlined, pure-play aesthetics company with a concentrated, competitive portfolio of differentiated injectable products. Effective, longer-lasting, natural looking, minimally...
19/09/2017 - 06:00 RNS
RNS Number: 0939R Sinclair Pharma PLC 19 September 2017 Sinclair Pharma plc Interim Results Strong underlying growth from key products, on track to meet full year guidance for EBITDA profit in 2017 Sinclair Pharma plc (SPH.L), ("Sinclair", or the "Group", or the "Company") the international aesthetics company, today announces its unaudited interim resu...
12/07/2017 - 06:47 RNS
RNS Number: 8190K Sinclair Pharma PLC 12 July 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: SINCLAIR PHARM...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment